Website Header with Language Selector and Dropdowns
Image

Orforglipron


Catalog Number: CL-ORFG-01
CAS No.: 2212020-52-3
Mol.F: C48H48F2N10O5
Mol.W: 883
Inv. Status: Custom Synthesis

Chemical Name: 3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one.

Country of Origin: India

Product Category: Orforglipron Impurities


Orforglipron is identified by CAS No. 2212020-52-3 and is chemically known as 3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one.

Orforglipron is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Orforglipron.

Page Keywords: Buy Orforglipron | Purchase Orforglipron | Orforglipron suppliers | Orforglipron manufacturers | Orforglipron price | Orforglipron Importer | Orforglipron Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-ORFG-03
CAS No: NA
Mol Wt: 883
Mol F: C48H48F2N10O5
Inv. Status: Custom Synthesis
CAT No: CL-ORFG-04
CAS No: NA
Mol Wt: 883
Mol F: C48H48F2N10O5
Inv. Status: Custom Synthesis
CAT No: CL-ORFG-02
CAS No: NA
Mol Wt: 883
Mol F: C48H48F2N10O5
Inv. Status: Custom Synthesis
CAT No: CL-ORFG-05
CAS No: 3067284-94-7
Mol Wt: 411.5
Mol F: C22H25N3O5
Inv. Status: Custom Synthesis
CAT No: CL-ORFG-06
CAS No: NA
Mol Wt: 411.5
Mol F: C22H25N3O5
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.